Nasdaq 100 At Risk Of Triggering A Multi-Week Corrective Decline Leg

This is less a broad risk-off tape than a regime change inside growth: the market is demanding proof that AI spend translates into free cash flow, not just top-line optionality. That immediately hurts the most crowded beneficiaries of the buildout chain — memory, networking, and the lowest-quality “AI-adjacent” names — because their multiples were priced off a straight-line capex supercycle. The first-order losers are the high-beta semis, but the bigger second-order loser is any vendor with heavy customer concentration to hyperscalers and weak conversion of bookings into cash.

The likely winners are the boring compounding businesses with visible margins: financials, healthcare, staples, and profitable software that can show revenue without rising capex intensity. If investors keep rotating out of long-duration tech, the relative performance spread can persist for 1-3 months, especially into earnings season when guidance becomes the real catalyst. A sustained de-rating in AI infrastructure would also pressure adjacent credit and convertibles exposed to levered chip and equipment names, creating forced-selling pockets beyond equities.

Contrarianly, the move may be getting ahead of itself if hyperscaler capex guides merely flatten rather than fall. In that case, the market has already discounted a slower monetization curve, and any evidence of better GPU utilization, inference demand, or enterprise AI payback could trigger a sharp mean reversion. The clean falsifier is simple: if the next round of cloud/semicap earnings keeps capex intact and free-cash-flow conversion holds, the valuation reset should stall; if not, the unwind likely extends through the next 4-8 weeks.